Episode Highlights

0:11 Intro
1:05 Introducing Stephanie Lovinsky-Desir, MD, MS
2:09 Understanding asthma endotypes and phenotypes
5:03 The effect of SMART guideline updates
11:50 Are pulmonary & allergy specialists adopting it?
12:46 The value of biologics in asthma care
18:11 Could they interrupt the atopic march?
19:53 COVID-19 risks in asthma
23:24 Environmental and non-viral illness impacts on asthma
26:11 Research into asthma care inequities
31:47 HFA-containing metered dose inhalers
35:37 Outro

In honor of World Asthma Day, Dr. Stephanie Lovinsky-Desir of Columbia University Irving Medical Center in New York visits our virtual studio to talk about all things asthma. Dr. Lovinsky-Desir, who has a deep understanding of how environmental factors impact children with asthma, touches upon inequities in asthma care, the role of climate change and COVID-19 lessons learned. She also hones in on whether biologic therapies may help interrupt pathways in the atopic march.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast